144 related articles for article (PubMed ID: 34604371)
1. Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Dogs With Tumors.
Kim J; Bae H; Ahn S; Shin S; Cho A; Cho KW; Jung DI; Yu D
Front Vet Sci; 2021; 8():735682. PubMed ID: 34604371
[TBL] [Abstract][Full Text] [Related]
2. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia.
Letendre JA; Goggs R
J Vet Emerg Crit Care (San Antonio); 2017 May; 27(3):307-314. PubMed ID: 28295988
[TBL] [Abstract][Full Text] [Related]
4. Investigation of cell-free DNA in canine plasma and its relation to disease.
Burnett DL; Cave NJ; Gedye KR; Bridges JP
Vet Q; 2016 Sep; 36(3):122-9. PubMed ID: 27103480
[TBL] [Abstract][Full Text] [Related]
5. Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.
Beffagna G; Sammarco A; Bedin C; Romualdi C; Mainenti M; Mollo A; Cavicchioli L; Ferro S; Trez D; De Maria R; Nitti D; Saccani A; Campanella M; Agostini M; Zappulli V
PLoS One; 2017; 12(1):e0169454. PubMed ID: 28081183
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma.
Eskandari M; Manoochehrabadi S; Pashaiefar H; Zaimy MA; Ahmadvand M
Blood Res; 2019 Jun; 54(2):114-119. PubMed ID: 31309089
[TBL] [Abstract][Full Text] [Related]
7. Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia.
Schaefer DM; Forman MA; Kisseberth WC; Lehman AM; Kelbick NT; Harper P; Rush LJ
Vet Comp Oncol; 2007 Sep; 5(3):145-55. PubMed ID: 19754786
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.
Kambayashi S; Ono N; Tone T; Baba K; Okuda M
Vet Comp Oncol; 2024 Jun; 22(2):303-309. PubMed ID: 38287199
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
[TBL] [Abstract][Full Text] [Related]
10. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes.
Letendre JA; Goggs R
J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):503-511. PubMed ID: 30299568
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA.
Tagawa M; Aoki M
Front Vet Sci; 2023; 10():1182093. PubMed ID: 37408834
[TBL] [Abstract][Full Text] [Related]
12. [Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance].
Chen YY; Guo SQ; Li YH; Wang DM; Liu X; Zhang YX; Wang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1390-1396. PubMed ID: 27784363
[TBL] [Abstract][Full Text] [Related]
13. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma cell-free DNA changes and lysyl oxidase during the treatment and prognosis of canine transmissible venereal tumors.
Mohamadzaheri M; Cheraghi H; Shirani D; Hatamkhani A
BMC Vet Res; 2022 Feb; 18(1):76. PubMed ID: 35189882
[TBL] [Abstract][Full Text] [Related]
15. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.
Tissot C; Toffart AC; Villar S; Souquet PJ; Merle P; Moro-Sibilot D; Pérol M; Zavadil J; Brambilla C; Olivier M; Couraud S
Eur Respir J; 2015 Dec; 46(6):1773-80. PubMed ID: 26493785
[TBL] [Abstract][Full Text] [Related]
16. The predictive and prognostic significance of cell-free DNA concentration in melanoma.
Váraljai R; Elouali S; Lueong SS; Wistuba-Hamprecht K; Seremet T; Siveke JT; Becker JC; Sucker A; Paschen A; Horn PA; Neyns B; Weide B; Schadendorf D; Roesch A
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):387-395. PubMed ID: 32569440
[TBL] [Abstract][Full Text] [Related]
17. Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
Delfau-Larue MH; van der Gucht A; Dupuis J; Jais JP; Nel I; Beldi-Ferchiou A; Hamdane S; Benmaad I; Laboure G; Verret B; Haioun C; Copie-Bergman C; Berriolo-Riedinger A; Robert P; Casasnovas RO; Itti E
Blood Adv; 2018 Apr; 2(7):807-816. PubMed ID: 29636326
[TBL] [Abstract][Full Text] [Related]
18. Plasma NT-proBNP and Cell-Free DNA Concentrations after Prolonged Strenuous Exercise in Working Farm Dogs.
Hunt H; Cave N; Bridges J; Gedye K; Hill K
J Vet Intern Med; 2018 Jan; 32(1):135-141. PubMed ID: 29197094
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias.
Mettler E; Fottner C; Bakhshandeh N; Trenkler A; Kuchen R; Weber MM
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205773
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation-Volvulus Syndrome.
Troia R; Giunti M; Calipa S; Goggs R
Front Vet Sci; 2018; 5():67. PubMed ID: 29686994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
